Mostrando 5 resultados de: 5
Filtros aplicados
Subtipo de publicación
Article(5)
Publisher
European Journal of Pharmacology(1)
Journal of Autonomic Pharmacology(1)
Journal of Pharmacy and Pharmacology(1)
Life Sciences(1)
Neuropharmacology(1)
Área temáticas
Farmacología y terapéutica(5)
Bioquímica(2)
Enfermedades(2)
Fisiología humana(1)
Mammalia(1)
Origen
scopus(5)
Characterization of [<sup>3</sup>H]nisoxetine binding in rat vas deferens membranes: Modulation by sigma and PCP ligands
ArticleAbstract: Sigma (σ) and phencyclidine (PCP) receptor ligands, apart from their main effects on σ receptors andPalabras claves:Noradrenaline transporter, PCP ligands, Sigma ligands, Vas deferens, [ H]nisoxetine 3Autores:Antoni Camins, Camarasa J., Escubedo E., Gasulla D., Pallás M., Pubill D., Sureda F.X.Fuentes:scopusAssessment of the adrenergic effects of orphenadrine in rat vas deferens
ArticleAbstract: The peripheral adrenergic effects of orphenadrine, an antiparkinsonian drug, have been evaluated inPalabras claves:Autores:Antoni Camins, Camarasa J., Canudas A.M., Escubedo E., Pallás M., Pubill D., Sureda F.X.Fuentes:scopusCarnosine prevents methamphetamine-induced gliosis but not dopamine terminal loss in rats
ArticleAbstract: The neuroprotective effect of carnosine, an endogenous antioxidant, was examined against methamphetaPalabras claves:Benzodiazepine receptor, peripheral-type, Carnosine, HSP27, Methamphetamine, [ H]GBR 12935 3, [ H]Paroxetine 3Autores:Antoni Camins, Camarasa J., Escubedo E., Pallás M., Pubill D., Sureda F.X., Verdaguer E.Fuentes:scopusEffect of PCP and sigma ligands on both noradrenaline- and electrically-induced contractions and on [<sup>3</sup>H]-noradrenaline uptake in rat vas deferens
ArticleAbstract: 1. Electrically induced contractions of the epididymal portion of rat vas deferens were potentiatedPalabras claves:Autores:Antoni Camins, Camarasa J., Canudas A.M., Escubedo E., Pallás M., Pubill D., Sureda F.X.Fuentes:scopusNeuroprotective action of flavopiridol, a cyclin-dependent kinase inhibitor, in colchicine-induced apoptosis
ArticleAbstract: Flavopiridol was developed as a drug for cancer therapy due to its ability to inhibit cell cycle proPalabras claves:Caspase-3, Cerebellar granule neurons, Cyclin-dependent kinases, flavopiridol, neuroprotection, Par-4Autores:Antoni Camins, Bravo R., Bruna A., Caelles C., Camarasa J., Canudas A.M., Escubedo E., Jiménez A., Jordá E.G., Pallás M., Pubill D., Verdaguer E.Fuentes:scopus